DOI:
10.1055/s-00000099
Zeitschrift für Orthopädie und Unfallchirurgie
LinksClose Window
References
Lohmander LS, Hellot S, Dreher D. et al.
Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.
Arthritis Rheumatol 2014;
66: 1820-1831
We do not assume any responsibility for the contents of the web pages of other providers.